Portman Square Capital’s CONMED CNMD Stock Holding History

Portman Square Capital’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,800	Closed	-$1.14M	–	260
2024 Q3	$1.14M	Sell	15,800 -84,200	-84%	-$5.94M	0.04%	265
2024 Q2	$6.93M	Hold	100,000	–	–	0.24%	120
2024 Q1	$8.01M	Hold	100,000	–	–	0.22%	122
2023 Q4	$11M	Buy	100,000 +6,500	+7%	+$672K	0.25%	103
2023 Q3	$9.43M	Buy	93,500 +20,000	+27%	+$2.3M	0.23%	111
2023 Q2	$9.99M	Sell	73,500 -115,800	-61%	-$14.1M	0.28%	91
2023 Q1	$19.7M	Buy	189,300 +98,300	+108%	+$9.51M	0.9%	25
2022 Q4	$8.07M	Buy	+91,000	New	+$7.55M	0.59%	42

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Portman Square Capital's CNMD Position: Q1 2025 in Review

Portman Square Capital sold out of CONMED (CNMD) in Q1 2025, closing a stake of 15,640 shares — an estimated $1.01M sold.

Portman Square Capital first reported a position in CNMD in Q4 2022 and held it in 7 quarters. The position peaked at $3.37M in Q2 2023. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

Portman Square Capital reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
Portman Square Capital sold 15,640 CONMED shares in Q1 2025, an estimated $1.01M.
Portman Square Capital first reported a position in CONMED in Q4 2022 and held it in 7 quarters.
Portman Square Capital's CONMED position peaked at $3.37M in Q2 2023.
280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Portman Square Capital's 13F filing for Q1 2025, filed 2 May 2025.